Reprogramming the immune system. Restoring lives. At COUR, we develop targeted therapies that incite calm within the immune system and help restore the health of people suffering from autoimmune diseases.
COUR will be facing some major Big Pharma peers in myasthenia; Argenx’s Vyvgart was approved for the disease in 2021 while Johnson & Johnson has filed for approval of nipocalimab and Amgen recently trumpeted positive late-stage results.
Coursera Inc. (COUR) reported first-quarter 2026 results.Revenue rose 9.2% year over year to $195.7
Coursera Inc. stocks have been trading down by -11.14 percent amid heightened concerns over slowing user growth and revenue forecasts. Key Takeaways Shares of Coursera Inc. (COUR) have dropped from the mid‑$6s to around $5.31, putting the stock back near recent support levels. Intraday trading shows COUR grinding sideways between roughly $5.05 and $5.35, signaling […]
What Happened? Shares of online learning platform Coursera (NYSE:COUR) jumped 8.4% in the afternoon session after the stock rebounded from a sell-off that followed its first-quarter earnings ...
Les Jackson is a Right-arm fast Bowler, who was born on , and has played for England teams so far. Talking about Test career, Les Jackson has taken a total of 7 wickets in 2 matches and 4 ...
PDF | The score has been developed for use of National Academy of Agricultural Sciences. For determining NAAS score of research journals, the Academy... | Find, read and cite all the research you ...
Advanced Materials Research (AMR) is a peer-reviewed journal which covers all aspects of theoretical and practical research of materials science: synthesis, analysis of properties, technologies of ...